DC-STAMP: A Key Regulator in Osteoclast Differentiation

Journal of Cellular Physiology

Volumn 231, Issue 11, 2016, Pages 2402-2407

  Chiu, Ya Hui ^a   Ritchlin, Christopher T ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; DENDRITIC CELL SPECIFIC TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; MICRORNA; MICRORNA 7B; OSTEOCLAST DIFFERENTIATION FACTOR; TAL L TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL VOLUME; CYTOSKELETON; FRACTURE; HOMEOSTASIS; HUMAN; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT;

EID: 84964883964     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25389     Document Type: Review

References (78)

1. Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes Jdel P, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH. Genetic Determinants of Paget's Disease C. 2011. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet 43:685–689.
2. Antonova E, Le TK, Burge R, Mershon J. 2013. Tibia shaft fractures: Costly burden of nonunions. BMC Musculoskelet Disord 14:42.
3. Beauregard M, Gagnon E, Guay-Belanger S, Morissette J, Brown JP, Michou L. 2014. Identification of rare genetic variants in novel loci associated with Paget's disease of bone. Hum Genet 133:755–768.
4. Bernard NJ. 2014. Osteoarthritis: Circulating miRNAs-early osteoarthritis biomarkers? Nat Rev Rheumatol 10:197.
5. Boyce BF. 2013a. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res 28:711–722.
6. Boyce BF. 2013b. Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res 92:860–867.
7. Bradaschia-Correa V, Moreira MM, Arana-Chavez VE. 2013. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. Cell Tissue Res 353:79–86.
8. Charles JF, Aliprantis AO. 2014. Osteoclasts: More than ‘bone eaters’. Trend Mol Med 20:449–459.
9. Chen J, Qiu M, Dou C, Cao Z, Dong S. 2015. MicroRNAs in bone balance and osteoporosis. Drug Dev Res 76:235–245.
10. Chiu Y-H, Schwarz E, Gladman D, Moorehead S, Smith M, Barrett R, Ritchlin C. 2012a. Transition from psoriasis to psoriatic arthritis is associated with increased level of circulating osteoclast precursors and increased expression of DC-STAMP. Arthritis Rheum 64:S1108.
11. Chiu YH, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT. 2012b. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 27:79–92.
12. Chiu YH, Ritchlin CT. 2012. Biomarkers to diagnose early arthritis in patients with psoriasis. Psoriasis Forum 18:2–10.
13. Choo MK, Yeo H, Zayzafoon M. 2009. NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 45:579–589.
14. Courtial N, Smink JJ, Kuvardina ON, Leutz A, Gothert JR, Lausen J. 2012. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J 26:523–532.
15. Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV. 2009. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int Orthop 33:1407–1414.
16. Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y, Xiang J, Xu J, Dong S. 2014. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. Biochim Biophys Acta 1839:1084–1096.
17. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. 2015. Biology of bone tissue: Structure, function, and factors that influence bone cells. BioMed Res Int 2015:421746.
18. Galliera E, Randelli P, Dogliotti G, Dozio E, Colombini A, Lombardi G, Cabitza P, Corsi MM. 2010. Matrix metalloproteases MMP-2 and MMP-9: Are they early biomarkers of bone remodelling and healing after arthroscopic acromioplasty? Injury 41:1204–1207.
19. Garlet GP, Martins W, Jr., Fonseca BA, Ferreira BR, Silva JS. 2004. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31:671–679.
20. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. 2005. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573.
21. Georgess D, Mazzorana M, Terrado J, Delprat C, Chamot C, Guasch RM, Perez-Roger I, Jurdic P, Machuca-Gayet I. 2014. Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts. Mol Biol Cell 25:380–396.
22. Hartgers FC, Vissers JL, Looman MW, van Zoelen C, Huffine C, Figdor CG, Adema GJ. 2000. DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur J Immunol 30:3585–3590.
23. Hobolt-Pedersen AS, Delaisse JM, Soe K. 2014. Osteoclast fusion is based on heterogeneity between fusion partners. Calcified Tissue Int 95:73–82.
24. Hughes CE, Finney BA, Koentgen F, Lowe KL, Watson SP. 2014. The N-terminal SH2 domain of Syk is required for (hem)ITAM but not integrin signalling in mouse platelets. Blood 125:144–154.
25. Humphrey MB, Lanier LL, Nakamura MC. 2005. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev 208:50–65.
26. Islam R, Bae HS, Yoon WJ, Woo KM, Baek JH, Kim HH, Uchida T, Ryoo HM. 2014. Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP. J Cell Physiol 229:2166–2174.
27. Izawa T, Zou W, Chappel JC, Ashley JW, Feng X, Teitelbaum SL. 2012. C-Src links a RANK/alphavbeta3 integrin complex to the osteoclast cytoskeleton. Mol Cell Biol 32:2943–2953.
28. Jager A, Zhang D, Kawarizadeh A, Tolba R, Braumann B, Lossdorfer S, Gotz W. 2005. Soluble cytokine receptor treatment in experimental orthodontic tooth movement in the rat. Eur J Orthodont 27:1–11.
29. Jansen BJ, Eleveld-Trancikova D, Sanecka A, van Hout-Kuijer M, Hendriks IA, Looman MG, Leusen JH, Adema GJ. 2009. OS9 interacts with DC-STAMP and modulates its intracellular localization in response to TLR ligation. Mol Immunol 46:505–515.
30. Kane D, Stafford L, Bresnihan B, FitzGerald O. 2003. A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology 42:1460–1468.
31. Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y. 2010. Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice. Bone 47:617–625.
32. Kawano H, Tanaka S, Ishii A, Cui D, Eguchi S, Hashimoto O, Ikeda E. 2011. Osteoclast-rich undifferentiated carcinoma of the urinary bladder: An immunohistochemical study. Pathol Res Pract 207:722–727.
33. Kim HC, Song JM, Kim CJ, Yoon SY, Kim IR, Park BS, Shin SH. 2015. Combined effect of bisphosphonate and recombinant human bone morphogenetic protein 2 on bone healing of rat calvarial defects. Maxillofac Plast Reconstr Surg 37:16.
34. Kim JB, Leucht P, Luppen CA, Park YJ, Beggs HE, Damsky CH, Helms JA. 2007. Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration. Bone 41:39–51.
35. Kim JK, Lee SM, Suk K, Lee WH. 2012. Synthetic peptides containing ITIM-like domains block expression of inflammatory mediators and migration/invasion of cancer cells through activation of SHP-1 and PI3K. Cancer Invest 30:364–371.
36. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N. 2008. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22:176–185.
37. Kondo M, Kondo H, Miyazawa K, Goto S, Togari A. 2013. Experimental tooth movement-induced osteoclast activation is regulated by sympathetic signaling. Bone 52:39–47.
38. Lee SM, Suk K, Lee WH. 2012. Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K. Clin Exp Immunol 167:438–446.
39. Li S, Miller CH, Giannopoulou E, Hu X, Ivashkiv LB, Zhao B. 2014. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. J Clin Invest 124:5057–5073.
40. Maruyama K, Uematsu S, Kondo T, Takeuchi O, Martino MM, Kawasaki T, Akira S. 2013. Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP. J Exp Med 210:1947–1960.
41. Matsumoto G, Ueda T, Sugita Y, Kubo K, Mizoguchi M, Kotani E, Oda N, Kawamata S, Segami N, Mori H. 2015. Polyhedral microcrystals encapsulating bone morphogenetic protein 2 improve healing in the alveolar ridge. J Biomater Appl 30:193–200.
42. Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279:26475–26480.
43. Mensah KA, Ritchlin CT, Schwarz EM. 2010. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. J Cell Physiol 223:76–83.
44. Miller GJ, Gerstenfeld LC, Morgan EF. 2015. Mechanical microenvironments and protein expression associated with formation of different skeltissues during bone healing. Biomech Model Mechanobiol 14:1239–1253.
45. Miyamoto H, Katsuyama E, Miyauchi Y, Hoshi H, Miyamoto K, Sato Y, Kobayashi T, Iwasaki R, Yoshida S, Mori T, Kanagawa H, Hujie A, Hao Wu, Morioka H, Matsumoto M, Toyama Y, Miyamoto T. 2012. An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion. J Bio Chem 287:32479–32484.
46. Nakashima T, Takayanagi H. 2009. Osteoimmunology: Crosstalk between the immune and bone systems. J Clin Immunol 29:555–567.
47. Nimmerjahn F, Ravetch JV. 2007. Fc-receptors as regulators of immunity. Adv Immunol 96:179–204.
48. Nimmerjahn F, Ravetch JV. 2008. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34–47.
49. Nishida T, Emura K, Kubota S, Lyons KM, Takigawa M. 2011. CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC- STAMP). J Bone Miner Res 26:351–363.
50. Penolazzi L, Lisignoli G, Lambertini E, Torreggiani E, Manferdini C, Lolli A, Vecchiatini R, Ciardo F, Gabusi E, Facchini A, Gambari R, Piva R. 2011. Transcription factor decoy against NFATc1 in human primary osteoblasts. Int J Mol Med 28:199–206.
51. Pountos I, Georgouli T, Pneumaticos S, Giannoudis PV. 2013. Fracture non-union: Can biomarkers predict outcome? Injury 44:1725–1732.
52. Ray BJ, Thomas K, Huang CS, Gutknecht MF, Botchwey EA, Bouton AH. 2012. Regulation of osteoclast structure and function by FAK family kinases. J Leukocyte Biol 92:1021–1028.
53. Rocha CA, Cestari TM, Vidotti HA, de Assis GF, Garlet GP, Taga R. 2014. Sintered anorganic bone graft increases autocrine expression of VEGF, MMP-2 and MMP-9 during repair of critical-size bone defects. J Mol Histol 45:447–461.
54. Saito W, Uchida K, Matsushita O, Inoue G, Sekiguchi H, Aikawa J, Fujimaki H, Takaso M. 2015. Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder. J Orthop Surg Res 10:59.
55. Sesler CL, Zayzafoon M. 2013. NFAT signaling in osteoblasts regulates the hematopoietic niche in the bone microenvironment. Clin Dev Immunol 107321.
56. Sissons JR, Peschon JJ, Schmitz F, Suen R, Gilchrist M, Aderem A. 2012. Cutting edge: MicroRNA regulation of macrophage fusion into multinucleated giant cells. J Immunol 189:23–27.
57. Soe K, Hobolt-Pedersen AS, Delaisse JM. 2015. The elementary fusion modalities of osteoclasts. Bone 73:181–189.
58. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702.
59. Stern PH. 2006. The calcineurin-NFAT pathway and bone: Intriguing new findings. Mol Interv 6:193–196.
60. Takito J, Nakamura M, Yoda M, Tohmonda T, Uchikawa S, Horiuchi K, Toyama Y, Chiba K. 2012. The transient appearance of zipper-like actin superstructures during the fusion of osteoclasts. J Cell Sci 125:662–672.
61. Takito J, Otsuka H, Yanagisawa N, Arai H, Shiga M, Inoue M, Nonaka N, Nakamura M. 2014. Regulation of osteoclast multinucleation by the actin cytoskeleton signaling network. J Cell Physiol 230:395–405.
62. Takito J, Otsuka H, Yanagisawa N, Arai H, Shiga M, Inoue M, Nonaka N, Nakamura M. 2015. Regulation of osteoclast multinucleation by the actin cytoskeleton signaling network. J Cell Physiol 230:395–405.
63. Teti A. 2013. Mechanisms of osteoclast-dependent bone formation. BoneKEy Rep 2:449.
64. Victoria G, Petrisor B, Drew B, Dick D. 2009. Bone stimulation for fracture healing: What's all the fuss? Indian J Orthop 43:117–120.
65. Vignery A. 2005. Macrophage fusion: The making of osteoclasts and giant cells. J Exp Med 202:337–340.
66. Wang L, Hsiao EC, Lieu S, Scott M, O'Carroll D, Urrutia A, Conklin BR, Colnot C, Nissenson RA. 2015a. Loss of G G-protein-coupled receptor signaling in osteoblasts accelerates bone fracture healing. J Bone Miner Res 30:1896–1904.
67. Wang L, Liu S, Zhao Y, Liu D, Liu Y, Chen C, Karray S, Shi S, Jin Y. 2015b. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass. Cell Death Differ 2:1654–1664.
68. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. 2006. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10:771–782.
69. Witwicka H, Hwang SY, Reyes-Gutierrez P, Jia H, Odgren PE, Donahue LR, Birnbaum MJ, Odgren PR. 2015. Studies of OC-STAMP in osteoclast fusion: A new knockout mouse model, rescue of cell fusion, and transmembrane topology. PloS ONE 10:e0128275.
70. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, 3rd, Frankel WN, Lee SY, Choi Y. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190–25194.
71. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345–351.
72. Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K, Hosogane N, Matsuo K, Toyama Y, Suda T, Miyamoto T. 2007. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J Bone Miner Res 22:992–1001.
73. Yang M, Birnbaum MJ, MacKay CA, Mason-Savas A, Thompson B, Odgren PR. 2008. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. J Cell Physiol 215:497–505.
74. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Nat Acad Sci USA 95:3597–3602.
75. Zeng Z, Zhang C, Chen J. 2013. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts. J Bone Miner Metab 31:409–416.
76. Zhang C, Dou C, Xu J, Dong S. 2014. DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis. J Cell Physiol 229:1330–1335.
77. Zhang F, Tanaka H, Kawato T, Kitami S, Nakai K, Motohashi M, Suzuki N, Wang CL, Ochiai K, Isokawa K, Maeno M. 2011. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts. Biochimie 93:296–305.
78. Zhao Q, Wang X, Liu Y, He A, Jia R. 2010. NFATc1: Functions in osteoclasts. Int J Biochem Cell Biol 42:576–579.